Oxford Biomedica notes the Japanese approval of Kymriah® (tisagenlecleucel), the first CAR-T cell therapy authorised in Asia

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence